Local Consolidation Therapy in Patients with EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Receiving Frontline Osimertinib, A Real-World Experience

Benyounes A
Additional contact information
Benyounes A: Inova Schar Cancer Institute, Fairfax, VA, USA

Biomedical Journal of Scientific & Technical Research, 2024, vol. 54, issue 3, 45833-45837

Abstract: This retrospective study aims to evaluate the impact of Local Consolidation Therapy (LCT) on progression-free survival (PFS) and overall survival (OS) in patients with stage IV EGFR-mutated non-small cell lung cancer (NSCLC) receiving frontline osimertinib treatment.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008541.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008541.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:54:y:2023:i:3:p:45833-45837

DOI: 10.26717/BJSTR.2024.54.008541

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().